Concentra 集团 CON

On August 4, 2026, Keith Newton, Chief Executive Officer of the Company and member of the Company's Board of Directors , notified the Board of his intent to resign from the role of Chief Executive Officer, effective November 1, 2026, and transition to Executive Chairman of the Board. William K. Newton has served as a director of the Company since June 2024 and has served as our Chief Executive Officer since rejoining in 2015 and our President until 2023. Mr. Newton was also Chairman of the Board of Directors for the Company from 2018 to 2022 when we were part of a joint venture between Select and Welsh Carson and other investors. Prior to 2015, Mr. Newton served in various management and operational roles at the Company and our predecessor, OccuSystems, from 1995 to 2011 and was promoted to President and Chief Operating Officer from 2007 to 2011. In 2011, Mr. Newton moved on to DentalOne Partners as President and Chief Operating Officer. Prior to joining OccuSystems in 1995, Mr. Newton worked for Columbia HCA's Ambulatory Surgery Division and its predecessor Medical Care International from 1991 to 1995. Prior to 1991, he had served in various accounting and finance roles at The Associates First Capital Corporation and was a CPA with KPMG Peat Marwick. Mr. Newton earned his Bachelor of Business Administration in accounting from Texas A&M University in 1985. Keith Newton will transition from Chief Executive Officer of the Company to serve as the Executive Chairman of the Company's Board of Directors with effect from 01st November 2026.

Matthew DiCanio has served as Concentra's (i) President since 2023 and (ii) Chief Financial Officer since 2024. Mr. DiCanio joined Concentra in 2015 as Senior Vice President, Strategy & Corporate Development. He was named Executive Vice President in 2021. Mr. DiCanio was previously responsible for Concentra's community-based outpatient center division (since divested) from 2016 to 2020. He also led the integration efforts for the Company's US HealthWorks acquisition from 2018 to 2020. Before joining Concentra, Mr. DiCanio held various positions in finance, mergers and acquisitions and management. Mr. DiCanio was Principal and Co-Head of the healthcare vertical at a middle-market investment bank in Dallas from 2012 to 2015, an investment banker with Bank of America Merrill Lynch in New York City from 2009 to 2012, and a CPA with KPMG, LLP from 2004 to 2007. After earning a B.S. in Business Administration from the University of Richmond, Mr. DiCanio later earned an MBA in Finance and Economics from Columbia Business School in New York. Matthew T. DiCanio will be appointed as President and Chief Executive Officer with effect from 01st November 2026.

Timothy Ryan has served as Concentra's Executive Vice President, Chief Legal Counsel since October 2024. Prior to joining Concentra, Mr. Ryan served as Chief Legal Counsel at AccentCare, Inc. a prominent home health care provider from 2015 to 2024. Prior to that, he held several key positions at UnitedHealth Group Incorporated (NYSE: UNH) from 1995 to 2014, culminating in his role as General Counsel of OptumHealth, a diversified health and well-being company. Earlier in his career, Mr. Ryan was a private practice attorney at law firms in Chicago and Detroit. Mr. Ryan earned his Bachelor of Business Administration from the University of Michigan and his Juris Doctor from Boston University in Boston, Massachusetts.

John Anderson, DO, FACOEM has served as Concentra's (i) Chief Medical Officer since 2014 and (ii) Executive Vice President since 2021. Dr. Anderson is a Fellow of the American College of Occupational and Environmental Medicine and is board certified in both occupational medicine and healthcare quality management. Dr. Anderson is a member of the American Osteopathic College of Occupational and Preventive Medicine, the American College of Occupational and Environmental Medicine, and American Board of Quality Assurance and Utilization Review Physicians as well as the American Osteopathic Association and the Michigan Occupational and Environmental Medical Association. He served as an appointed member of the Michigan Workers' Compensation Advisory Council from 1988 to 2009 and Wayne State University's Occupational Medicine Resident Advisory Committee from 1996 to 2008. Dr. Anderson received his baccalaureate degree from John Carroll University and his Osteopathic medical degree from Kansas City University. Dr. Anderson also received a Business of Medicine Executive Graduate Certificate from Johns Hopkins University School of Medicine. On April 10, 2026, Dr. John Anderson notified Concentra Group Holdings Parent, Inc. (the Company) of his retirement from his position as Executive Vice President and Chief Medical Officer of the Company effective as of December 31, 2026. Dr. John R. Anderson notified Concentra Group Holdings Parent, Inc. of his retirement from his position as Executive Vice President and Chief Medical Officer of the Company effective as of December 31, 2026.

Vipin Gopal has served as a director of the Company since July 2025. Mr. Gopal previously served as (i) Chief Data and Analytics Officer of Walgreens Boots Alliance from 2023 to 2024 and (ii) Senior Vice President, Chief Data and Analytics Officer of Eli Lilly and Company (NYSE: LLY) from 2018 to 2023, where he oversaw enterprise data, analytics and AI strategy, governance and solutions. Previously, Mr. Gopal served in multiple roles, including as the Senior Vice President of Analytics, at Humana Inc. (NYSE: HUM) from 2009 to 2018. Mr. Gopal previously held various leadership roles at Cigna Group (NYSE: CI), United Technologies Corporation (NYSE: UTX, now RTX Corporation), and Honeywell International Inc. (Nasdaq: HON). Mr. Gopal obtained his doctorate from Carnegie Mellon University and B.Tech. from the Indian Institute of Technology, Bombay, both in engineering, and holds a Master of Business Administration from the NYU Stern School of Business. Mr. Gopal is a Certified Corporate Director from the National Association of Corporate Directors (NACD).

Brigid A. Bonner has served as a director of the Company since July 2025. Since 2007, Ms. Bonner has served as President of Bonner Consulting, which specializes in strategy, leadership development, digital transformation, and consumer experience design. From 2015 to 2021, Ms. Bonner was Chief Experience Officer of the global nonprofit social network CaringBridge, where she oversaw product development, marketing, product design, customer experience and fundraising. Mr. Bonner previously served as a director of Workiva Inc. (NYSE: WK) from 2018 to 2025. Prior to CaringBridge, she held executive roles at Schwan's Home Service; UnitedHealth Group Inc. (NYSE: UNH); SimonDelivers; Target Corp. (NYSE: TGT); and International Business Machines Corporation (NYSE: IBM). Ms. Bonner is a Certified Corporate Director from the NACD. Bonner earned a Bachelor of Science degree from Iowa State University, with a double major in journalism/advertising and industrial administration, and a Master of Business Administration degree from Harvard Business School.

Daniel J. Thomas has served as a director of the Company since June 2024 and as a director of Select since July 2019. Mr. Thomas currently serves on the board of directors of National Partners in Healthcare, Revelohealth and Equalis Group LLC and previously served on the board of directors of Healthcare Highways, Inc. and Accentcare, Inc. In addition, from June 2018 through January 2019, Mr. Thomas served as President and CEO of National Partners in Healthcare. From 2011 until his retirement in 2017, Mr. Thomas served as President, Chief Executive Officer and a board member of Provista, Inc. Prior to Provista, Mr. Thomas served as Chief Executive Officer and a board member of Viant, Inc. Before the formation of Viant, from 1993 through 2007, Mr. Thomas spent 14 years with the Company and held the positions of President, Chief Executive Officer and Chief Operating Officer.

Marc R. Watkins, MD has served as a director since July 2024. Dr. Watkins has spent over five years in senior medical oversight roles at Concentra Inc. Previously, Dr. Watkins served as the Chief Medical Officer of Kroger Health from 2018 to 2025, following a similar role at The Little Clinic from 2015 to 2018. Dr. Watkins currently serves as clinical advisor to CookUnity, Inc., Osara Health, Inc. and Care Eco Inc. Previously, Dr. Watkins held various leadership positions at Concentra, including National Medical Director and Zone Worksite Medical Director. Between 2008 and 2009, he was an Interim Medical Director for the North American division of Nissan Motor Co. Ltd. Between 2003 and 2007, Dr. Watkins was a senior medical officer at a US Marine Corps Station. Between 2005 and 2006 he was group surgeon of Camp Al Asad in Iraq. Dr. Watkins has held over a dozen advisory roles, board seats, or other positions at U.S. healthcare companies and healthcare nonprofits, as well as U.S. educational institutions, including as an adjunct professor in the pharmacy department of the University of Cincinnati. Dr. Watkins earned his M.D. from Meharry Medical College and has a Master of Science in Public Health.

Cheryl B. Pegus, MD, MPH has served as a director since July 2024. Dr. Pegus is currently the Chief Executive Officer and Chair of Intellihealth, Inc. d/b/a FlyteHealth, a position she has held since August 2025. Dr. Pegus has more than 30 years of experience across the healthcare sector, serving as a member of the Board of Directors of Boston Scientific (NYSE: BSX), and as a partner at Morgan Health focused on improving the quality, affordability and equity of health care. Dr. Pegus is also President of Caluent, LLC, a healthcare analytics and advisory company she has owned since 2012. Dr. Pegus previously served as Executive Vice President of Health & Wellness for Walmart from December 2020 through March 2023, where she led the company's health care businesses, and served as a senior advisor. Prior to that, Dr. Pegus served as Chief Medical Officer and President of Consumer Health Solutions for Cambia Health Solutions, from September 2018 to December 2020. Dr. Pegus also served as the first Chief Medical Officer of Walgreens from 2010 to 2013, and from 2007 to 2010, as General Manager and Chief Medical Officer of SymCare Personalized Health Solutions, Inc., a diabetes-focused division of Johnson & Johnson. Prior to that, Dr. Pegus served as a Medical Director at Aetna and Pfizer. She began her career in private practice as a cardiologist and currently serves on the boards of a number of charitable and private organizations, including the American Heart Association. Dr. Pegus previously served as a director of Phreesia, Inc., Tactile Systems Technology, Inc. and Cogentix Medical, Inc. Dr. Pegus received her B.A. from Brandeis University, her M.D. from Weill Cornell Medical College, and her M.P.H. from Columbia University Mailman School of Public Health.

Robert A. Ortenzio has served as a director of the Company since June 2024. Mr. Ortenzio co-founded Select and served as Select's President and Chief Operating Officer from February 1997 to September 2001. Mr. Ortenzio served as Select's President and Chief Executive Officer from September 2001 to January 1, 2005 and has served as a director of Select since February 1997. On January 1, 2014, Mr. Ortenzio was appointed as Select's Executive Chairman and Co-Founder. Mr. Ortenzio was an Executive Vice President and a director of Horizon/CMS Healthcare Corporation from July 1995 until July 1996. In 1986, Mr. Ortenzio co-founded Continental Medical Systems, Inc., and served in a number of different capacities, including as a Senior Vice President from February 1986 until April 1988, as Chief Operating Officer from April 1988 until July 1995, as President from May 1989 until August 1996 and as Chief Executive Officer from July 1995 until August 1996. Before co-founding Continental Medical Systems, Inc., Mr. Ortenzio was a Vice President of Rehab Hospital Services Corporation. Robert Ortenzio, the Chair of the Board, has notified the Board of his intent to resign from the role of Chair of the Board while continuing to serve as a director of the Board, effective as of November 1, 2026.

Mr. T. Newton, serves as the Company's Senior Vice President, Strategy & Finance, since January 2025. Prior to joining the Company, Mr. T. Newton served as a Principal at Tailwater Capital LLC, a Dallas-based private equity firm, from January 2017 to January 2025. Prior to joining Tailwater Capital LLC, Mr. T. Newton served as Investment Banking Analyst at Piper Sandler & Co., an investment bank, from July 2014 to January 2017. Mr. T. Newton holds a Master of Science in Finance from Texas A&M University and a Bachelor of Business Administration, Accounting and Business Honors from Texas A&M University. On September 8, 2026, the Company announced the appointment of Tanner Newton as Executive Vice President and Chief Financial Officer of the Company, effective November 1, 2026

Su Zan Nelson, CPA has served as Concentra's Executive Vice President, Chief Accounting Officer since 2024. Previously, Ms. Nelson served as Concentra's Chief Financial Officer from 2016 to 2024. Ms. Nelson initially joined Concentra in 2001. In 2014, Ms. Nelson served as interim Chief Financial Officer for DentalOne Partners, a dental management service organization supporting 160 dental practices, and in 2015, Ms. Nelson served as the Chief Financial Officer for MedPost Urgent Care, a division of Tenet Healthcare Corporation (NYSE: THC). Ms. Nelson's experience also includes healthcare related financial consultation to several leading corporations. Ms. Nelson earned her bachelor's degree in finance from the University of Texas at Arlington and is a CPA.

Giovanni Gallara, PT, DPT has served as Concentra's Executive Vice President, Chief Clinical Services Officer since 2021. Previously, Mr. Gallara served as Concentra's Senior Vice President from 2016 to 2021. Mr. Gallara served as Concentra's Vice President of Therapy Operations, supporting the Northeast and Mid-Atlantic regions from 2011 to 2016. Prior to joining Concentra, Mr. Gallara worked in the financial services industry, outpatient rehabilitation clinical operations, onsite clinical care model delivery for Fortune 500 companies, and academics. Mr. Gallara received his undergraduate degree from Stockton University, Master's degree in Physical Therapy from UMDNJ-Rutgers University, and Doctor of Physical Therapy from the University of Montana.

Danielle Kendall has served as Concentra's Executive Vice President, Chief People Officer since November 2024. Previously, Ms. Kendall served as Concentra's (i) Senior Vice President, Human Resources from 2015 to 2024 and (ii) Vice President, Human Resources from 2007 to 2015. Ms. Kendall has served in various positions with Concentra since 2000. Prior to joining Concentra, Ms. Kendall served in human resources leadership roles at multi-site organizations across a variety of industries, including computer retail with CompUSA, Inc., dental management care, and life insurance. After earning an athletic scholarship in swimming, Ms. Kendall earned her Bachelor's in Business Administration from Texas Christian University and maintains her SHRM-Senior Certified Professional (SHRM-SCP) and Senior Professional Human Resources designations in Human Resources.

Michael Kosuth has served as Concentra's Executive Vice President, Chief Operating Officer - East since 2021. Previously, Mr. Kosuth served as Concentra's (i) Senior Vice President, Chief Operating Officer - East from 2018 to 2021 and (ii) Senior Vice President, Operations from 2015 to 2018. Mr. Kosuth has been employed by Concentra since 1996, serving in various positions. Mr. Kosuth has a Bachelor of Science from the University of Akron and a Master of Business Administration from Kent State University.

Thomas Devasia has served as Concentra's Executive Vice President, Chief Marketing and Innovation Officer since 2022. Previously, Mr. Devasia served as Concentra's Senior Vice President from 2020 to 2022. Since joining Concentra in 2016, Mr. Devasia has overseen our product, marketing, and digital teams. Prior to joining Concentra, Mr. Devasia held various leadership positions in consumer innovation, product development, business strategy and planning, marketing, and brand management at global and U.S. Fortune 100 healthcare companies. Mr. Devasia earned dual Bachelor of Arts degrees in biology and business from Bellarmine University and holds an MBA in marketing and international business from Xavier University.

Jonathan Conser has served as Concentra's Executive Vice President, Chief Growth and Customer Officer since 2023. Previously, Mr. Conser served as Concentra's Senior Vice President from 2016 to 2023. Since joining Concentra in 2003, Mr. Conser has served as Vice President of National Accounts in Concentra's managed care division and most recently as Concentra's Chief Sales Officer. Prior to joining Concentra, Mr. Conser held various management sales leadership positions with financial, insurance, automotive, and oil and gas companies. He received a Bachelor of Business Administration in business from Southern Methodist University.

Douglas McAndrew has served as Concentra's Executive Vice President, Chief Operating Officer - West since 2021. Previously, Mr. McAndrew served as Concentra's Senior Vice President, Chief Operating Officer - West from 2018 to 2021 and as Senior Vice President, Operations from 2015 to 2018. During his tenure at Concentra, Mr. McAndrew has served in a variety of roles that included National Director / AVP of Sales, National Director of Episodic Services, Vice President of Specialty Services and Senior Vice President of Operations. Mr. McAndrew has a Bachelor of Science in Business Administration from Texas State University.